Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Exelixis is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases. The majority of its programs focus on the discovery and development of small molecule drugs for cancer. The Company has a pipeline of compounds in various stages of development for the treatment of cancer and various metabolic, cardiovascular and inflammatory disorders. All of its development compounds were generated through its internal drug discovery activities, although it is developing certain of these compounds in collaboration with partners and has out-licensed to others. The Company is focusing its development activities on its clinical compounds, XL184, XL147 and XL765. XL184, the Company's advanced drug candidate, inhibits MET, VEGFR2 and RET, proteins that are key drivers of tumor growth and/or vascularization. XL147 is a selective inhibitor of PI3K while XL765 is a dual inhibitor of PI3K and mTOR.

Since our founding in May 1998 we have been focused on the impact of cortisol and the potential benefits of developing glucocorticoid receptor antagonists. About 80 percent of the tissues in the body have receptors for cortisol, and the effects of excess cortisol are severe and often life-threatening. Our initial research has been with mifepristone, which potently blocks the cortisol receptor. On February 17, 2012, the FDA approved Korlym® (mifepristone) in the United States as a once-daily oral medication for treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. Mifepristone is also being studied in a phase 3 trial, evaluating the impact of cortisol blockade on the psychotic features of psychotic depression. We plan to continue enrolling patients in this study throughout 2013.

Wholesales pharmaceutical products

Manufactures pharmaceuticals

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

The American Can Company was a manufacturer of tin cans. It was a member of the Tin Can Trust, that controlled a "large percentage of business in the United States in tin cans, containers, and packages of tin." American Can Company ranked 97th among United States corporations in the value of World War II military production contracts. It was formerly a member of the Dow Jones Industrial Average from 1959–1991, though after 1987 it had renamed itself Primerica, a financial conglomerate which had divested itself of its packaging arm in 1986.

Bayer Schering Pharma AG is a research-centered pharmaceutical company that was formed by the merger of Schering with Bayer on 29 December 2006. The company was originally founded in 1851 by Ernst Christian Friedrich Schering. The company employs more than 26,000 people in 140 subsidiaries all over the world. The company's headquarters are in Berlin-Wedding, Germany and the forerunner company Schering's annual gross revenue was nearly € 5 billion. They retain the largest German manufacturing facility which is located in Bergkamen. The company focuses on the business areas of gynaecology and andrology, oncology, and also special therapeutics, diagnostical devices, and nuclear medicine. Schering's best-known product is their line of combined oral contraceptive pills. Through Bayer Healthcare AG, Bayer Schering Pharma is a full member of the European Federation of Pharmaceutical Industries and Associations.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Changsha Materials Technology Co., Ltd., established on 2019-02-28, Business scope includes new materials and related technologies,technology of building engineering materials,Chemical Products,chemical technology,Network technology research and development;New material technology promotion service;Chemical Engineering Research Services;New Energy Technology Development,Consulting and Assignment;Engage in the following business activities on the Internet:building materials,decorative material,Chemical Products,Non-metallic minerals and products,Wholesale of metals and metal ores;Chemical reagents and daily chemical products(Free of hazardous and monitored chemicals)retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) Business activities can only be carried out after approval by relevant departments)

Hebei Fanke New Material Co., Ltd., established on 2013-07-22, Business scope includes liquid crystal materials and chemical products(Precursors,Excluding hazardous chemicals)research and development,Production,Sales;Cyclopropylmethanol(12Ton/year),Hydrocarbon cleanerB(208Ton/year),Hydrocarbon cleanerG(275Ton/year)production(Valid until2023year10moon09day);Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(law,Matters prohibited or restricted by regulations and decisions of the State Council shall not be operated;Matters requiring approval from other departments,after approval,before operating)

Evonik Operations GmbH manufactures specialty chemicals. The company was founded on August 23, 2000 and is headquartered in Weatherford, TX.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Merck (d.b.a. EMD Millipore in the U.S. and Canada) is a German chemical and pharmaceutical company. Merck, also known as “German Merck” and “Merck Darmstadt”, was founded in Darmstadt, Germany, in 1668, making it the world's oldest operating chemical and pharmaceutical company. The company was privately owned until going public in 1995. However, the Merck family still controls a majority (≈70%) of the company's shares. Following World War I, Merck lost possession of its foreign sites, including the Merck & Co. subsidiary in the United States. Merck & Co., which operates as Merck Sharp and Dohme (MSD) outside the U.S. and Canada, is now an independent company. Merck KGaA operates mainly in Europe, Africa, Asia, Oceania and Latin America. Since Merck & Co. holds the rights to the Merck name in the U.S. and Canada, the company operated under the umbrella brand EMD Chemicals in North America, and since 2010 as EMD Millipore (after the acquisition of Millipore Corporation), formed from the initials of Emanuel Merck, Darmstadt. Founded in 1668 in Darmstadt, Merck KGaA of Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The success of the export business to the United States led in 1887 to the establishment of an office in New York, which gave rise to their subsidiary [Merck & Co.](http://www.crunchbase.com/organization/merck-co-inc) four years later. Owing to World War I, Merck & Co. was expropriated in 1917. The two companies have been separate every since. Merck KGaA Subsidiaries: - [Merck Consumer Healthcare](http://www.crunchbase.com/organization/merck-consumer-healthcare) - [Merck Performance Materials](http://www.crunchbase.com/organization/merck-performance-materials)

Dongguan Julei Industrial Co., Ltd., established on 2015-04-23, Business scope includes production and sales:water-based paint,nanomaterials(Free of Hazardous Chemicals)(Another branch of production);engaged in electronic components,Electrical Equipment,building materials(Does not contain steel),Computers and Accessories,metallic material,communication equipment,Lubricating oil,Plastic and its products,Rubber and its products,Paint and its products,Ink and its products,Paraffin,Wood pulp and other cellulose pulp,chemical product(except dangerous goods)Filling Additives,Processing aids,Accelerator,wooden product,nanomaterials,Graphene material,Technology development and sales of non-metallic minerals;Import and export,Technology Import and Export.(The above projects do not involve special management measures for foreign investment access)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Suzhou Ruierkang Technology Co., Ltd., established on 2019-06-10, Business scope includes licensed projects:Production of Class II Medical Devices;Class III medical device business;Cosmetic production;Disinfectant production(Free of Hazardous Chemicals);Import and export;Technology Import and Export;Import and export agency;Production of Class III Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Synthetic Materials Sales;Advertising Design,acting;advertisement making;Graphic design and production;Daily necessities sales;General merchandise sales;sales agent;Domestic trade agent;Trademark agency;Biochemical product technology research and development;Disinfectant sales(Free of Hazardous Chemicals);Sales of Class II Medical Devices;Sales of Class I Medical Devices;Cosmetics Wholesale;advertising(non-broadcasting station,television station,Newspaper Publishing Unit);Sales of plastic products;Metal Material Sales;Metal Products Sales;Machinery sales;Production of Class I Medical Devices;ink sales(Free of Hazardous Chemicals);Manufacturing of plastic products;Manufacture of special equipment for plastic processing;Sales of special equipment for plastic processing;Sales of engineering plastics and synthetic resins(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Henan Academy of Sciences Institute of Chemistry Co., Ltd., established on 1991-01-19, business scope includes,inorganic chemistry,Research and development of polymer chemistry and chemical technology consulting services;analysis test;Chemical new product development,Sales(Excluding flammable and explosive dangerous goods);Plastic raw materials and products,Development of rubber products,Research;Realtor.